Niederndodeleben, Germany

Lars Fahsel

This inventor holds 1 USPTO granted patent. Top assignee: Losan Pharma Gmbh. Active years: 2013.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lars Fahsel: Innovator in Pharmaceutical Composition

Introduction

Lars Fahsel is a notable inventor based in Niederndodeleben, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the effectiveness of pharmaceutical compositions through advanced coating techniques.

Latest Patents

Lars Fahsel holds a patent for a "Melt-coated pharmaceutical composition with fast release." This invention relates to a process for producing a solid, coated pharmaceutical composition by a melt coating process. The process is designed to provide a solid, coated pharmaceutical composition that ensures a fast release of the active ingredients, thereby improving therapeutic outcomes.

Career Highlights

Lars Fahsel is associated with Losan Pharma GmbH, a company known for its commitment to developing high-quality pharmaceutical products. His role at the company has allowed him to leverage his expertise in pharmaceutical sciences to create innovative solutions that address the needs of patients and healthcare providers.

Collaborations

Lars has collaborated with several professionals in his field, including Peter Kraahs and Stefanie Bold. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge pharmaceutical technologies.

Conclusion

Lars Fahsel's contributions to the pharmaceutical industry exemplify the impact of innovation in drug delivery systems. His patent for a melt-coated pharmaceutical composition highlights his commitment to improving patient care through advanced technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…